Short answer
Genpact LTD (G) filed its Q3 2014 10-Q quarterly report on Nov 7, 2014 for the quarter ended Sep 30, 2014.
Genpact LTD Q3 2014 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Q3 revenue $588.1M, up 9.9% YoY from $534.9M, led by Global Clients revenue of $470.8M, up 12.9%
- BPO revenue $446.8M, up 11.2%, outperforming IT Services revenue of $141.3M, up 6.1%
- Gross margin 39.7% vs 38.4%; operating margin 12.4% vs 16.1%; net margin 7.9% vs 13.4%
- Cash $399.2M vs $571.3M at December 31, 2013; operating cash flow $178.8M for nine months vs $233.2M
- Capital deployment included $123.7M for Pharmalink, $47.6M of property purchases, and $302.6M for share repurchases; wage inflation and GE BPO declines remained headwinds
Risk Factors
- Newly added risk not identifiable, provided text contains no Risk Factors discussion or quarter-specific additions
- Regulatory risk: $43 million India tax assessment order for 2009-2010 transactions, under appeal
- Operational risk: GE revenue concentration remained material at 19.9% of third-quarter revenue
- Financial risk: $165.0 million short-term borrowings outstanding, versus none at December 31, 2013
- Currency risk: foreign-exchange loss $12.1 million for nine months, versus gain $24.6 million in 2013
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other Genpact LTD quarterly reports
- Q3 2019 10-QFiled Nov 8, 2019
- Q2 2019 10-QFiled Aug 9, 2019
- Q1 2019 10-QFiled May 10, 2019
- Q3 2018 10-QFiled Nov 9, 2018
- Q2 2018 10-QFiled Aug 9, 2018
- Q1 2018 10-QFiled May 10, 2018
- Q3 2017 10-QFiled Nov 9, 2017
- Q2 2017 10-QFiled Aug 9, 2017
- Q1 2017 10-QFiled May 10, 2017
- Q3 2016 10-QFiled Nov 8, 2016
- Q2 2016 10-QFiled Aug 8, 2016
- Q1 2016 10-QFiled May 9, 2016
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.